Esquea, E. M., Ciraku, L., Young, R. G., Merzy, J., Talarico, A. N., Ahmed, N. N., . . . Dick, A. (2024). Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells. Frontiers in pharmacology, 15, 1394685. https://doi.org/10.3389/fphar.2024.1394685
Citace podle Chicago (17th ed.)Esquea, Emily M., et al. "Selective and Brain-penetrant ACSS2 Inhibitors Target Breast Cancer Brain Metastatic Cells." Frontiers in Pharmacology 15 (2024): 1394685. https://doi.org/10.3389/fphar.2024.1394685.
Citace podle MLA (9th ed.)Esquea, Emily M., et al. "Selective and Brain-penetrant ACSS2 Inhibitors Target Breast Cancer Brain Metastatic Cells." Frontiers in Pharmacology, vol. 15, 2024, p. 1394685, https://doi.org/10.3389/fphar.2024.1394685.